The assumption in this study is that adverse events for each drug are equivalent and, consequently, adverse events are not taken into consideration for the cost and effectiveness measurements.
Este estudio supone que los episodios adversos para cada medicamento son equivalentes, por lo que las medidas de costo y efectividad no tienen en cuenta episodios adversos.